Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-02-21 2020-02-21
Drug Identification Number 02169126 02169126
Brand name TEVA-COTRIDIN TEVA-COTRIDIN
Common or Proper name COTRIDIN SYRUP COTRIDIN SYRUP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PSEUDOEPHEDRINE HYDROCHLORIDE TRIPROLIDINE HYDROCHLORIDE CODEINE PHOSPHATE PSEUDOEPHEDRINE HYDROCHLORIDE TRIPROLIDINE HYDROCHLORIDE CODEINE PHOSPHATE
Strength(s) 30MG 2MG 10MG 30MG 2MG 10MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 2L 2L
ATC code R05DA R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-29 2020-01-29
Estimated end date 2020-03-31 2020-03-31
Actual end date 2020-02-20 2020-02-20
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments